References and Notes
<A NAME="RG24910ST-1A">1a</A>
Borges F.
Roleira F.
Milhazes N.
Santana L.
Uriarte E.
Curr. Med. Chem.
2005,
12:
887
<A NAME="RG24910ST-1B">1b</A>
Kostova I.
Curr.
Med. Chem.: Anti-Cancer Agents
2005,
5:
29
<A NAME="RG24910ST-1C">1c</A>
Kulkarni MV.
Kulkarni GM.
Lin C.-H.
Sun C.-M.
Curr.
Med. Chem.
2006,
13:
2795
<A NAME="RG24910ST-1D">1d</A>
Semeniuchenko V.
Groth U.
Khilya V.
Synthesis
2009,
3533
<A NAME="RG24910ST-1E">1e</A>
Riveiro ME.
De Kimpe N.
Moglioni A.
Vazquez R.
Monczor F.
Shayo C.
Davio C.
Curr.
Med. Chem.
2010,
17:
1325
<A NAME="RG24910ST-2A">2a</A>
Rajanarendar E.
Ramu K.
Ramesh P.
Indian J. Chem., Sect. B: Org.
Chem. Incl. Med. Chem.
2004,
43:
1790
<A NAME="RG24910ST-2B">2b</A>
Reddy NS.
Gumireddy K.
Mallireddigari MR.
Cosenza S.
Venkatapuram P.
Bell SC.
Reddy EP.
Ramana Reddy MVR.
Bioorg. Med. Chem.
2005,
13:
3141
<A NAME="RG24910ST-3">3</A>
Zaha AA.
Hazem A.
New Microbiol.
2002,
25:
213
<A NAME="RG24910ST-4">4</A>
Finn GJ.
Creaven B.
Egan DA.
Melanoma
Res.
2001,
11:
461
<A NAME="RG24910ST-5">5</A>
Budzisz E.
Brzezinska E.
Krajewska U.
Różalski M.
Eur. J.
Med. Chem.
2003,
38:
597
<A NAME="RG24910ST-6">6</A>
Reddy NS.
Mallireddigari MR.
Cosenza S.
Gumireddy K.
Bell SC.
Reddy EP.
Reddy MVR.
Bioorg. Med.
Chem. Lett.
2004,
14:
4093
<A NAME="RG24910ST-7">7</A>
Donnelly DMX.
Boland GM.
Nat.
Prod. Rep.
1995,
12:
321
<A NAME="RG24910ST-8A">8a</A>
Petragnani N.
Ferraz HMC.
Silva GVJ.
Synthesis
1986,
157
<A NAME="RG24910ST-8B">8b</A>
Kitson RRA.
Millemaggi A.
Taylor RJK.
Angew. Chem. Int. Ed.
2009,
48:
9426
<A NAME="RG24910ST-8C">8c</A>
Albrecht Ł.
Wojciechowski J.
Albrecht A.
Wolf WM.
Janecka A.
Studzian K.
Krajewska U.
Różalski M.
Janecki T.
Krawczyk H.
Eur. J.
Med. Chem.
2010,
45:
710
<A NAME="RG24910ST-9">9</A>
Harmon AD.
Hutchinson CR.
J. Org. Chem.
1975,
40:
3474
<A NAME="RG24910ST-10">10</A>
Groutas WC.
Felker D.
Magnin D.
Synth.
Commun.
1980,
10:
355
<A NAME="RG24910ST-11A">11a</A>
Sunitha K.
Balasubramanian KK.
Rajagopalan K.
Tetrahedron
Lett.
1984,
25:
3125
<A NAME="RG24910ST-11B">11b</A>
Sunitha K.
Balasubramanian KK.
Rajagopalan K.
J. Org. Chem.
1985,
50:
1530
<A NAME="RG24910ST-11C">11c</A>
Krishnamoorthy TV.
Rajagopalan K.
Balasubramanian KK.
Tetrahedron
Lett.
1985,
26:
1747
<A NAME="RG24910ST-11D">11d</A>
Sunitha K.
Balasubramanian KK.
Rajagopalan K.
Tetrahedron Lett.
1985,
26:
4393
<A NAME="RG24910ST-11E">11e</A>
Drewes SE.
Emslie ND.
Karodia N.
Loizou G.
Synth. Commun.
1990,
20:
1437
<A NAME="RG24910ST-11F">11f</A>
Foucaud A.
Brine N.
Synth. Commun.
1994,
24:
2851
<A NAME="RG24910ST-11G">11g</A>
Liu Y.
Qian J.
Lou S.
Xu Z.
Synlett
2009,
2971
<A NAME="RG24910ST-12">12</A>
Bestmann HJ.
Lehnen H.
Tetrahedron Lett.
1991,
32:
4279
<A NAME="RG24910ST-13A">13a</A>
Falsone G.
Cateni F.
De Nardo MM.
Darai MM.
Z. Naturforsch., B
1993,
48:
1391
<A NAME="RG24910ST-13B">13b</A>
Krawczyk H.
Albrecht Ł.
Wojciechowski J.
Wolf WM.
Tetrahedron
2007,
63:
12583
<A NAME="RG24910ST-14">14</A>
Janecki T.
Wąsek T.
Tetrahedron
2004,
60:
1049
<A NAME="RG24910ST-15">15</A>
Janecki T.
Albrecht A.
Koszuk JF.
Modranka J.
Sowak D.
Tetrahedron
Lett.
2010,
51:
2274
<A NAME="RG24910ST-16">16</A>
General Procedure
for the Synthesis of 3-Diethoxy-phosphorylchromen-2-ones 6a-c
and 2-Diethoxy-phosphoryldihydrobenzochromen-3-ones 8a,b: To
a solution of the corresponding phenol 5a-c (11 mmol) or naphthol 7a,b (11 mmol) in CH2Cl2 (50
mL), trifluoro-methanesulfonic acid (3.00 g, 20 mmol) or methanesulfonic acid
(1.92 g, 20 mmol) and acrylate 4 (2.66
g, 10 mmol) were added and the resulting mixture was stirred at
r.t. for the period of time given in Table
[¹]
. Next, sat. aq NaHCO3 solution
was added (100 mL). Extraction with CH2Cl2 (3 × 30
mL), drying (MgSO4) and evaporation of the solvent gave the
crude product, which was purified by crystallization from Et2O.
Diethyl (7-Methoxy-2-oxo-2
H
-chromen-3-yl)-phosphonate
(6a): orange solid; mp 64-65 ˚C. IR (film): 1726,
1601, 1228, 1134, 1016 cm-¹. ¹H
NMR (250 MHz, CDCl3): δ = 1.35 [t, ³
J
HP = 7.1 Hz, 6 H,
(CH
3CH2O)2P(O)], 3.88
(s, 3 H, MeO), 4.14-4.31 [m, 4 H, (CH3CH
2O)2P(O)], 6.69
(d, 4
J
HH = 2.4
Hz, 1 H, CH-Ar), 6.87 (dd, ³
J
HH = 8.7
Hz, 4
J
HH = 2.4
Hz, 1 H, CH-Ar), 7.46 (d, ³
J
HH = 8.7
Hz, 1 H, CH-Ar), 8.43 (d, ³
J
HP = 17.4
Hz, 1 H, H-4). ¹³C NMR (62.9 MHz, CDCl3): δ = 16.18 [d, ³
J
PC = 6.4 Hz, (CH3CH2O)2P(O)], 55.81
(s, MeO), 62.97 [d, ²
J
PC = 5.8
Hz, (CH3
CH2O)2P(O)], 100.38
(s, C-Ar), 111.49 (d, ³
J
PC = 14.3
Hz, C-Ar), 112.84 (d, ¹
J
PC = 198.9
Hz, C-3), 113.16 (s, C-Ar), 130.33 (s, C-Ar), 153.19 (d, ²
J
PC = 7.0 Hz, C-4),
157.31 (s, C-Ar), 158.37 (d, ²
J
PC = 15.0
Hz, C-2), 164.72 (s, C-Ar). ³¹P NMR
(101 MHz, CDCl3): δ = 12.47. Anal.
Calcd for C14H17O6P: C, 53.85;
H, 5.49. Found: C, 53.64; H, 5.52.
Diethyl
(3-Oxo-3
H
-benzo[
f
]chromen-2-yl)
phosphonate (8a): orange solid; mp 136-137 ˚C.
IR (film): 1732, 1604, 1256, 1136, 1024 cm-¹. ¹H
NMR (250 MHz, CDCl3): δ = 1.38-1.44 [m,
6 H, (CH
3CH2O)2P(O)],
4.15-4.39 [m, 4 H, (CH3CH
2O)2P(O)],
7.48 (d, ³
J
HH = 9.0
Hz, 1 H, CH-Ar), 7.61 (t, ³
J
HH = 9.0
Hz, 1 H, CH-Ar), 7.75 (t, ³
J
HH = 9.0
Hz, 1 H, CH-Ar), 7.93 (d, ³
J
HH = 7.2
Hz, 1 H, CH-Ar), 8.10 (d, ³
J
HH = 7.2
Hz, 1 H, CH-Ar), 8.37 (d, ³
J
HH = 9.0
Hz, 1 H, CH-Ar), 9.30 (d, ³
J
HP = 17.6
Hz, 1 H, H-1). ¹³C NMR (62.9 MHz, CDCl3): δ = 16.27 [d, ³
J
PC = 6.3 Hz, (CH3CH2O)2P(O)], 63.30 [d, ²
J
PC = 5.9 Hz, (CH3
CH2O)2P(O)],
112.20 (s, C-Ar), 115.70 (d, ¹
J
PC = 197.0
Hz, C-2), 116.52 (s, C-Ar), 121.45 (s, C-Ar), 126.43 (s, C-Ar),
128.97 (s, C-Ar), 129.12 (s, 2 × C-Ar), 130.08 (s, C-Ar),
135.82 (s, C-Ar), 148.99 (d, ²
J
PC = 7.4 Hz,
C-1), 155.79 (s, C-Ar), 158.23 (d, ²
J
PC = 14.5 Hz, C-3). ³¹P
NMR (101 MHz, CDCl3): δ = 12.38. Anal.
Calcd for C17H17O5P: C, 61.45;
H, 5.16. Found: C, 61.67; H, 4.89.
<A NAME="RG24910ST-17">17</A>
General Procedure
for the Synthesis of 3-Diethoxy-phosphorylchroman-2-ones 12a-l
and 3-Diethoxy-phosphoryldihydrobenzochromen-2-ones 14a-h:
To a solution of the corresponding chromenones 6a-c (1 mmol) or benzochromenones 8a,b (1 mmol)
and a catalytic amount of CuI (19 mg, 0.1 mmol) in THF (10 mL) a
solution of Grignard reagent 11a-d (5 mmol) was added dropwise, under an
argon atmosphere at r.t. (Me, n-Bu and i-Pr magnesium iodides were prepared
from the corresponding alkyl halides and magnesium in Et2O;
vinylmagnesium bromide was purchased from ALDRICH®).
The solution was stirred for 48 h. After this time the reaction
mixture was quenched with H2O (2 mL), acidified to pH
ca. 1.5 with 10% aq HCl solution and extracted with CHCl3 (4 × 10
mL). The organic extracts were washed with brine (10 mL) and dried over
MgSO4. Evaporation of the solvent gave the crude product
which was purified by column chromatography (eluent: EtOAc-hexane,
3:1).
Diethyl
trans
-(7-Methoxy-4-methyl-2-oxochroman-3-yl)phosphonate
(12a): colorless oil. IR (film): 1762, 1625, 1257, 1229, 1147,
1015 cm-¹. ¹H NMR
(250 MHz, CDCl3): δ = 0.94 [t, ³
J
HH = 7.1 Hz, 3 H,
CH
3CH2OP(O)],
1.29 (dd, ³
J
HH = 7.2
Hz, ³
J
HH = 1.8
Hz, 3 H, Me), 1.31 [t, ³
J
HH = 7.1 Hz, 3 H,
CH
3CH2OP(O)],
3.28 (dd, ²
J
HP = 25.0
Hz, ³
J
HH = 1.1
Hz, 1 H, CH-3), 3.42-3.58 [m, 2 H, CH3CH
2OP(O)], 3.71-3.85
(m, 4 H, MeO, CH-4), 4.05-4.17 [m, 2 H, CH3CH
2OP(O)], 6.59 (d, 4
J
HH = 2.5 Hz, 1 H,
CH-Ar), 6.70 (dd, ³
J
HH = 8.4
Hz, 4
J
HH = 2.5
Hz, 1 H, CH-Ar), 7.12 (d, ³
J
HH = 8.4
Hz, 1 H, CH-Ar). ¹³C NMR (62.9 MHz,
CDCl3): δ = 15.74 [d, ³
J
PC = 6.1 Hz, CH3CH2OP(O)],
15.96 [d, ³
J
PC = 6.3 Hz, CH3CH2OP(O)],
23.64 (d, ³
J
PC = 18.6
Hz, Me), 31.56 (d, ²
J
PC = 4.3
Hz, C-4), 47.19 (d, ¹
J
PC = 127.7
Hz, C-3), 55.32 (s, MeO), 61.75 [d, ²
J
PC = 7.0 Hz, CH3
CH2OP(O)], 62.92 [d, ²
J
PC = 6.8 Hz, CH3
CH2OP(O)], 91.80
(s, C-Ar), 102.05 (s,
C-Ar), 110.64 (s, C-Ar), 117.26
(s, C-Ar), 128.10 (s, C-Ar), 151.37 (s, C-Ar), 159.65 (s, C-Ar),
163.50 (d, ²
J
PC = 6.0
Hz, C-2). ³¹P NMR (101 MHz, CDCl3): δ = 19.20.
Anal. Calcd for C15H21O6P: C, 54.88;
H, 6.45. Found: C, 54.97; H, 6.61.
Diethyl
trans
-(1-Methyl-3-oxo-2,3-dihydro-1
H
-benzo[
f
]chromen-2-yl)phosphonate
(14a): yellow oil. IR (film): 1764, 1440, 1392, 1260, 1232,
1224, 1160, 1024 cm-¹. ¹H
NMR (250 MHz, CDCl3): δ = 0.73 [t, ³
J
HH = 7.1 Hz, 3 H, CH
3CH2OP(O)],
1.27 [t, ³
J
HH = 7.1
Hz, 3 H, CH
3CH2OP(O)], 1.44
(dd, ³
J
HH = 7.2
Hz, ³
J
HH = 1.8
Hz, 3 H, Me), 3.28-3.38 (m, 1 H, CH-1), 3.47 (dd, ²
J
HP = 25.3 Hz, ³
J
HH = 1.2 Hz, 1 H, CH-2),
3.59-3.69 [m, 1 H, CH3CH
2OP(O)], 4.04-4.16 [m,
2 H, CH3CH
2OP(O)],
4.24-4.39 [m, 1 H, CH3CH
2OP(O)], 7.21-7.26
(m, 1 H, CH-Ar), 7.44-7.50 (m, 1 H, CH-Ar), 7.56-7.63
(m, 1 H, CH-Ar), 7.76-7.87 (m, 2 H, 2 × CH-Ar), 7.96-8.00
(m, 1 H, CH-Ar). ¹³C NMR (62.9 MHz,
CDCl3): δ = 15.64 [d, ³
J
PC = 6.1 Hz, CH3CH2OP(O)],
16.07 [d, ³
J
PC = 6.2
Hz, CH3CH2OP(O)],
21.72 (d, ³
J
PC = 18.4
Hz, Me), 28.48 (d, ²
J
PC = 4.2
Hz, C-1), 47.01 (d, ¹
J
PC = 127.6
Hz,
C-2), 62.84 [d, ²
J
PC = 6.9 Hz, CH3
CH2OP(O)], 63.15 [d, ²
J
PC = 6.7 Hz, CH3
CH2OP(O)], 116.95
(s, C-Ar), 118.49 (s,
C-Ar), 122.35 (s, C-Ar), 125.16
(s, C-Ar), 127.48 (s, C-Ar), 128.71 (s, C-Ar), 129.13 (s, C-Ar),
130.25 (s, C-Ar), 131.04 (s, C-Ar), 148.29 (s, C-Ar), 163.74 (d, ²
J
PC = 5.8 Hz, C-3). ³¹P
NMR (101 MHz, CDCl3): δ = 18.72. Anal.
Calcd for C18H21O5P: C, 62.07;
H, 6.08. Found: C, 62.37; H, 6.23.
<A NAME="RG24910ST-18">18</A>
General Procedure
for the Synthesis of 3-Methylidene-chroman-2-ones 13a-l
and 2-Methylidenedihydro-benzochromen-3-ones 15a-h:
To a solution of the corresponding chromanones 12a-l (0.5 mmol) or benzochromenones 14a-h (0.5
mmol) in THF (5 mL), t-BuOK (67 mg, 0.6
mmol) or NaH (14 mg, 0.6 mmol) was added and the resulting mixture
was stirred at r.t. for 30 min. Then paraformaldehyde (75 mg, 2.5
mmol) was added in one portion. After 1.5 h, the reaction mixture
was quenched with brine (5 mL), THF was removed under reduced pressure
and the aqueous layer was extracted with CH2Cl2 (3 × 10
mL). The organic layer was dried over MgSO4 and the solvent
was evaporated. The crude product was purified by column chromatography
(eluent: CH2Cl2).
7-Methoxy-4-methyl-3-methylidenechroman-2-one (13a):
colorless oil. IR (film): 1755, 1441, 1258, 1192, 1014 cm-¹. ¹H
NMR (250 MHz, CDCl3): δ = 1.39 (d, ³
J
HH = 7.1 Hz, 3 H,
CH
3CH), 3.78 (s, 3 H, MeO),
3.74 (q, ³
J
HH = 7.1
Hz, 1 H, CH-4), 5.73 (dd, 4
J
HH = 0.9
Hz, ²
J
HH = 1.3
Hz, 1 H, CH2=C), 6.33 (dd, 4
J
HH = 0.9 Hz, ²
J
HH = 0.9 Hz, 1 H, CH
2=C), 6.61 (d, 4
J
HH = 2.5 Hz, 1 H,
CH-Ar), 6.69 (dd,
³
J
HH = 8.4
Hz, 4
J
HH = 2.5
Hz, 1 H, CH-Ar), 7.08 (d, ³
J
HH = 8.4
Hz, 1 H, CH-Ar). ¹³C NMR (62.9 MHz,
CDCl3): δ = 22.81 (s, Me), 36.59 (s,
C-4), 55.50 (s, MeO), 102.54 (s,
C-Ar), 110.94 (s, C-Ar),
118.85 (s, C-5), 126.99 (s, CH2=C), 127.33
(s, C-Ar), 138.20 (s, CH2=C),
150.76 (s, C-6), 159.64 (s, C-Ar), 163.49 (s, C-2). Anal. Calcd
for C12H12O3: C, 70.57; H, 5.92.
Found: 70.30; H, 5.81.
1-Methyl-2-methylidene-1,2-dihydrobenzo[
f
]chromen-3-one
(15a): pale-yellow oil. IR (film): 1756, 1440, 1224, 1160,
1024 cm-¹. ¹H NMR
(250 MHz, CDCl3): δ = 1.51 (d, ³
J
HH = 7.2 Hz, 3 H,
CH
3CH), 4.47 (q, ³
J
HH = 7.2 Hz, 1 H,
CH-1), 5.88 (s, 1 H, CH2=C), 6.44 (s, 1 H, CH2=C),
7.25-7.28 (m, 1 H, CH-Ar), 7.46-7.52 (m, 1 H,
CH-Ar), 7.58-7.65 (m, 1 H, CH-Ar), 7.76-7.97 (m,
3 H, 3 × CH-Ar). ¹³C NMR (69.2
MHz, CDCl3): δ = 21.76 (s, Me), 33.11
(s, C-1), 115.83 (s, C-Ar), 118.23 (s, C-Ar), 120.44 (s, C-Ar),
123.38 (s,
C-Ar), 125.53 (s, CH2=C),
126.37 (s, C-Ar), 127.22 (s,
C-Ar), 127.29 (s, C-Ar),
128.37 (s, C-Ar), 129.38 (s, C-Ar), 136.18 (s, CH2=C), 145.60 (s, C-Ar), 161.48 (s, C-3).
Anal. Calcd for C15H12O2: C, 80.34;
H, 5.39. Found: 80.01; H, 5.23.